Liver Diseases: all 2,094 studies
Page 9 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-surveyCompletedNCT05765890
- SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With ObesityCompletedNCT05764811Not applicable
- A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Hepatic Impairment Compared With Matched Healthy ParticipantsCompletedNCT05753592Phase 1
- Pharmacokinetics of Mitiperstat in Participants With Hepatic ImpairmentCompletedNCT05751759Phase 1
- A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedNCT05742919Phase 1
- NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced FibrosisStatus unknownNCT05734599
- A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver ProblemsCompletedNCT05731908Phase 1
- Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With RitonavirStatus unknownNCT05731804Phase 1
- Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle MassCompletedNCT05729269
- Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular DisorderStatus unknownNCT05719857Not applicable
- A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic FunctionCompletedNCT05718258Phase 1
- Different Regimens of Vitamin D in Treatment of Children With Chronic Liver DiseaseCompletedNCT05717569Not applicable
- The Nijmegen-Leiden-Amsterdam 2-tiered Care Path StudyCompletedNCT05712603
- A Study of Mezigdomide in Healthy Participants and Participants With Hepatic ImpairmentCompletedNCT05707390Phase 1
- Effect of Indian Hepatoprotective Diet in Reversibility of NAFLDStatus unknownNCT05696808Not applicable
- Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue AssessmentCompletedNCT05694923Not applicable
- Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLDStatus unknownNCT05686174Phase 1
- Detection of Jaundice From Ocular Images Via Deep LearningStatus unknownNCT05682105
- A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic FunctionCompletedNCT05674474Phase 1
- Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseCompletedNCT05669677
- REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept StudyCompletedNCT05663944Phase 2
- Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT05654129Not applicable
- Restrictive Fluid Management In Liver Transplantation (REFIL) - PilotActive, not recruitingNCT05647733Not applicable
- SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic OutcomesStatus unknownNCT05637866
- Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLDStatus unknownNCT05635474Not applicable
- Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver DysfunctionCompletedNCT05628493
- A Pharmacokinetic Study of TS-142 in Patients with Hepatic ImpairmentCompletedNCT05624944Phase 1
- Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease PatientsStatus unknownNCT05613192Phase 3
- Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver DiseaseCompletedNCT05611567Not applicable
- A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic FunctionCompletedNCT05610657Phase 1
- A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic ImpairmentCompletedNCT05607173Phase 1
- Liver Fibrosis and Steatosis in dm Non Invasive EvaluationStatus unknownNCT05605717
- Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric UnitCompletedNCT05602870Not applicable
- N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver DiseaseCompletedNCT05589584Phase 3
- Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled TrialCompletedNCT05579158Not applicable
- High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05578404Phase 2
- Validation of the New Vibration-guided FibroScan ExaminationCompletedNCT05567328Not applicable
- Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction PatientsStatus unknownNCT05559242Phase 1
- Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT05556135
- Study to Evaluate the Safety, Tolerability, and PK of PacritinibCompletedNCT05552183Phase 1
- Weight Gain After Smoking Cessation and NAFLDCompletedNCT05550688
- Intestinal Microbiota Transplant in Alcohol-Associated Liver DiseaseActive, not recruitingNCT05548452Phase 1/2
- Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease PatientsCompletedNCT05546450Not applicable
- Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese ChildrenCompletedNCT05527938Not applicable
- Clinical Epidemiology of NAFLD in Children and AdolescentsStatus unknownNCT05526274
- Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLDCompletedNCT05523648Early Phase 1
- Exercise and Cerebral Hemodynamics in MAFLD.Status unknownNCT05520697Not applicable
- First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT05517564Phase 1
- A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic ImpairmentCompletedNCT05517525Phase 1
- Pharmacokinetics of Cotadutide in Participants With Hepatic ImpairmentTerminatedNCT05517226Phase 1
- Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT05515445Phase 1
- Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular StressWithdrawnNCT05514470Not applicable
- Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05513729
- Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic CystsStatus unknownNCT05500157Not applicable
- Treating Pediatric NAFLD with NutritionCompletedNCT05499585Not applicable
- An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT05497765Not applicable
- Hepatobiliary Manifestations Following Two-Stages Elective Laparoscopic Restorative Proctocolectomy for Patients With Ulcerative Colitis. A Prospective Observational Study.CompletedNCT05495178
- Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy ParticipantsWithdrawnNCT05490030Phase 1
- Screening of Liver Fibrosis in Adults Without Known Liver DiseaseStatus unknownNCT05486767
- Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by UltrasoundStatus unknownNCT05486429
- Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced FibrosisCompletedNCT05485714
- A Randomized Controlled Trial Evaluating the Role of Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary SurgeryCompletedNCT05481398Not applicable
- Non-alcoholic Fatty Liver Disease and Its TreatmentCompletedNCT05480007Not applicable
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD PatientsCompletedNCT05474560Phase 4
- Prospective Analysis of In Vivo Laparoscopic Microwave Ablation ThermodynamicsCompletedNCT05471596
- Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543CompletedNCT05467722Phase 1
- Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASHActive, not recruitingNCT05462353Phase 2
- Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT05459701Phase 4
- Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and EfficiencyCompletedNCT05459155Not applicable
- Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function TestsStatus unknownNCT05457543
- Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver TransplantationStatus unknownNCT05457114
- No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet ElectrodesStatus unknownNCT05449873Not applicable
- Alcohol, Gut Leakiness, & Liver DiseaseCompletedNCT05428072Early Phase 1
- A Digital Solution for Individuals With Non Alcoholic Fatty Liver DiseaseCompletedNCT05426382Not applicable
- Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05422092Not applicable
- Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Status unknownNCT05421572
- Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver DiseaseCompletedNCT05419765
- The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease EvolutionCompletedNCT05416970
- A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control ParticipantsCompletedNCT05409911Phase 1
- Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative CareCompletedNCT05407272Not applicable
- To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic FunctionCompletedNCT05404529Phase 1
- To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota ModulationCompletedNCT05402449Not applicable
- Association Between Serum Ferritin Level and Severity of Liver Disease and Development of HCC in Cirrhotic PatientsStatus unknownNCT05401890
- Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma TreatmentStatus unknownNCT05397860Not applicable
- Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)CompletedNCT05392452Not applicable
- Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy SubjectsCompletedNCT05391724Phase 1
- Intraoperative Normal Saline Administration and Acute Kidney Injury in Patients Undergoing Liver TransplantationStatus unknownNCT05386953
- The Visceral Adiposity Measurement and Observation StudyCompletedNCT05383456
- A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic ImpairmentTerminatedNCT05376839Phase 1
- Effectiveness of Nurse-led Physical Therapy in Terms of Patient Competency, Patient Engagement and Physical Performance.CompletedNCT05376826Not applicable
- Aromatherapy Massage for Itching Management in Liver DiseasesCompletedNCT05367414Not applicable
- Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)Status unknownNCT05358496
- Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASHCompletedNCT05357248Not applicable
- Application of NGS in Ascites InfectionStatus unknownNCT05352152
- How Well do we Feed the Critically Ill PatientsCompletedNCT05347888
- Effect of Molecular Hydrogen in Patients With NAFLDCompletedNCT05325398Not applicable
- Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) StudyCompletedNCT05309642Not applicable
- A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05308160Phase 3
- Omics-based Predictors of NAFLD/Potential NASHStatus unknownNCT05301231
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906CompletedNCT05296733Phase 1